 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/368231
Point of Care Diagnostics Market in the US: Opportunities and Challenges
|
Description: |
Diagnosing at the point of care offers many advantages: increased patient empowerment, improved clinical outcomes, and fewer days at the hospital. As a result, physicians are ordering more point of care tests and companies are racing to meet growing demand. Their efforts are made easier by improved knowledge of diseases and drug responses at the molecular level and improved technologies that enable simpler, more self-contained testing. These trends, according to a new report are expected to drive double-digit growth over the next five years. According to this new report, the market is expected to grow from $5.5 billion in 2005 to as much as $7.5 billion in 2010.
But this opportunity is not without challenges. Point of care diagnostics is a highly competitive and challenging marketplace, with more than 50 companies and 40 types of tests, not to mention regulatory guidelines, reimbursement challenges, and information technology infrastructure needs. Moreover, point of care testing is inherently more expensive than central laboratory-based testing on a per test basis, resulting in intense price pressure. Success in this market depends on a detailed understanding of the trends, the unmet needs, the technologies, and the prices.
This new report is the ideal tool for planning for success. The comprehensive analysis of the US market is based on
(1) a proprietary comprehensive database of tests, (2) discussions with clinicians, (3) detailed assessments of current and emerging technologies, and (4) CDC, FDA, and professional organizational guidelines and publications.
Twenty-one figures, 32 tables, and profiles of 57 companies present the information in a simple and readily accessible manner. This report is the go-to tool for those wishing to enter and those wishing to stay current in this dynamic market. |
|
Contents: |
EXECUTIVE SUMMARY
INTRODUCTION
Figure 1 - Examples Of Tests Performed In Various Point Of Care Settings Figure 2 - Logic Tree For Determining If A Diagnostic Is Appropriate For Use As A POCT
Technologies Used in Point of Care Testing
Introduction
Figure 3 - A Variety Of Technologies Are Used In POC Testing. Immunoassays Figure 4 - Solid Phase Or Dipstick Immunoassay Figure 5 - Agglutination Test Figure 6 - Lateral Flow Test Enzymatic assays Figure 7 - Example Of An Enzymatic Reaction Used To Measure Glucose Chemical measurements Amperometric methods-electrodes Figure 8 - Clark-Type Oxygen Sensing Electrode
INFORMATION TECHNOLOGY AND DATA INTEGERATION
INFORMATION TECHNOLOGY AND DATA MANAGEMENT COMPANIES SERVING THE POINT OF CARE MARKET
REGULATORY COMPLIANCE FOR POINT OF CARE TESTING
POINT OF CARE TESTS ON MARKET BY APPLICATION
Asthma Theophylline Testing Table 1 - POC Theophylline Test Blood Gas Measurements Blood Electrolyte Testing Hemoglobin Table 2 - POC Blood Gas, Electrolyte And Hemoglobin Tests Cardiovascular Disease BNP- B -Type Natriuretic Peptide, a Biochemical Marker for Heart Failure Table 3 - Point of Care Tests for BNP CK-MB Troponins Myoglobin Table 4 - POC Tests for Markers Associated with Acute Cardiac Syndrome Cholesterol and Triglycerides Table 5 - POC Tests to Measure Cholesterol and Lipids Kidney Disease Urinary albumin Table 6 - Point of Care Tests for Microalbuminuria Diabetes Glucose Monitoring Table 7 - Bedside Glucose Monitors Glycosylated Hemoglobin (glycohemoglobin, hemoglobin A1c) Table 8 - POC HbA1c Tests Urine and Blood Ketones Table 9 - POC Tests for Blood Ketones Hemostasis aPTT-Activated Partial Thromboplastin Time Test ACT-Activated Clotting Time Test PT-Prothrombin Time, International Normalized Ratio Table 10 - POC Blood Clotting Tests D-dimer Table 11 - POC D-Dimer Tests Platelet Function Tests Table 12 - POC Platelet Function Tests Infectious Disease Lyme Disease Table 13 - POC Test for Detection of Borrelia burgdorferi Chlamydia Table 14 - POC Tests for Detection of Chlamydial Infection Clostridium difficile Table 15 - POC Tests for Detection of Clostridium difficile H. pylori Table 16 - POC Tests for Detection of H. Pylori HIV Table 17 - POC Tests for HIV Infectious Mononucleosis Table 18 - POC Tests for Infectious Mononucleosis Infectious Vaginitis Table 19 - POC Tests for Infectious Vaginitis Influenza Table 20 - POC Tests for Influenza Legionella pneumophila Table 21 - POC Test for Legionella pneumophila RSV Table 22 - POC Tests for RSV Streptococcal Infections-StrepA Table 23 - POC Tests for Streptococcus pyogenes Trichomonas Vaginitis Table 24 - POC Test for Trichomonas vaginitis Inflammatory disease CRP-C-reactive Protein Table 25 - POC Tests for C-Reactive Protein Perinatal, Neonatal care Hyperbilirubinemia Table 26 - POC Bilirubin Tests ROM Table 27 - POC Test for Ruptured Fetal Membranes Oncology Alpha-fetoprotein (AFP) Blood Test Table 28 - POC Test for Alpha-fetoprotein PSA Table 29 - POC Tests for Prostate Specific Antigen NMP22 Table 30 - POC Tests for NMP22 Fecal Occult Blood Table 31 - POC Tests for Fecal Occult Blood
TRENDS AND UNMET NEEDS MARKET DRIVERS MARKET MODELS
Aggregate Market
Figure 9 - Numbers of Companies with Offerings
Figure 10 - Numbers of Point of Care Tests Offered by Indication Market Sizes and Trends
Figure 11 - Market Sizes for POCT Addressing Cardiovascular Health, Inflammation, Asthma Figure 12 - Market Sizes for POCT Addressing Infectious Diseases Figure 13 - Market Sizes for POCT in Support Of Diabetes Treatment Figure 14 - Market Sizes for POCT Assisting in The Diagnosis Of Cancer Figure 15 - Market Sizes For Instrumentation Supporting POCT
Test Costs
Figure 16 - List Prices for POCTs Addressing Infectious Disease Figure 17 - List Prices for POCT Addressing Cardiovascular Disease, Hemostasis And Inflammatory Disease Figure 18 - List Prices for POCT Aiding In The Management Of Diabetes. Figure 19 - List prices of Instrumentation Supporting Cardiovascular Disease, Hemostasis And Inflammatory Disease POCT Figure 20 - List Prices for POC Instruments And Monitors Aiding In The Management Of Diabetes.
Incidence and Prevalence of Indications Served by Point of Care Testing
Figure 21 - US Incidence Of Acute Disease Indications Supported By POCT Figure 22 - US Prevalence Of Chronic Diseases Supported By POC Diagnostics
APPENDIX METHODOLOGY
Author Credentials Market Model Sources
APPENDIX II LIST OF 2006 CLIA-WAIVED TESTS
Hematology Urinalysis/Clinical Microscopy Chemistry Toxicology Bacteriology Virology Immunology
Appendix III Company Profiles
Abbott Diagnostics Abaxis Accumetrics AccuTech, LLC AGEN Biomedical Limited Avox Systems, Inc Axis-Shield PoC Bayer HealthCare Diagnostics Division Beckman Coulter BD (Becton, Dickinson and Company) Binax Bio-Rad Laboratories Biosite Cholestech Cortez Diagnostics, Inc. Dade Behring Diagnostic Chemicals Limited Dräger Medical AG & Co. KG Farallon Medical, Inc. Fujiribio Diagnostics Genzyme Diagnostics Germaine Laboratories, Inc. Helena Laboratories Corporation HemoCue Inc. HemoSense, Inc. Hypoguard USA, Inc. Immunostics, Inc. Instrumentation Laboratory Company International Technidyne (ITC) Inverness Medical Innovations Inc JANT PHARMACAL Corporation LifeScan, Inc Medtronic Diabetes N-Dia Inc. Nova Biomedical Corporation OraSure Technologies, Inc. Osmetech, Inc. Orion Diagnostica PerMaxim Polymedco Inc Polymer Technology Systems, Inc. (PTS) Princeton BioMeditech Provalis plc Quidel Corporation Radiometer America Inc. Reichert, Inc. Remel Respironics, Inc. Response Biomedical Corp Roche Diagnostics SA Scientific, Ltd. Serim Research Corporation Sienco, Inc. Stanbio Laboratory Teco Diagnostics Trinity Biotech Plc ZymeTx, Inc. |
|
Companies Mentioned |
Abbott Diagnostics
Abaxis
Accumetrics
AccuTech, LLC
AGEN Biomedical Limited
Avox Systems, Inc
Axis-Shield PoC
Bayer HealthCare Diagnostics Division
Beckman Coulter
BD (Becton, Dickinson and Company)
Binax
Bio-Rad Laboratories
Biosite
Cholestech
Cortez Diagnostics, Inc.
Dade Behring
Diagnostic Chemicals Limited
Dräger Medical AG & Co. KG
Farallon Medical, Inc.
Fujirebio Diagnostics
Genzyme Diagnostics
Germaine Laboratories, Inc.
Helena Laboratories Corporation
HemoCue Inc.
HemoSense, Inc.
Hypoguard USA, Inc.
Immunostics, Inc.
Instrumentation Laboratory Company
International Technidyne (ITC)
Inverness Medical Innovations Inc
JANT PHARMACAL Corporation
LifeScan, Inc
Medtronic Diabetes
N-Dia Inc.
Nova Biomedical Corporation
OraSure Technologies, Inc.
Osmetech, Inc.
Orion Diagnostica
PerMaxim
Polymedco Inc
Polymer Technology Systems, Inc. (PTS)
Princeton BioMeditech
Provalis plc
Quidel Corporation
Radiometer America Inc.
Reichert, Inc.
Remel
Respironics, Inc.
Response Biomedical Corp
Roche Diagnostics
SA Scientific, Ltd.
Serim Research Corporation
Sienco, Inc.
Stanbio Laboratory
Teco Diagnostics
Trinity Biotech Plc
ZymeTx, Inc. |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/368231
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 27/11/2009 20:11:34 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Point of Care Diagnostics Market in the US: Opportunities and Challenges
|
|
Web Address: |
http://www.researchandmarkets.com/reports/368231
|
|
Office Code: |
|
OC8HJNPOUMUXU
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Site License
|
|
€2,451.00
|
|
Hard Copy
|
|
€2,451.00 + EUR€ 50.00 Shipping/Handling *
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
 |
Page 2 of 2 Printed 27/11/2009 20:11:34
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder's Name: |
 |
|
|
|
Cardholder's Signature: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
 |
 |
|
|